(PRWEB) February 28, 2013
In July 2012, Stryker Orthopaedics issued a voluntary recall of two of its hip replacement products, the Rejuvenate Modular and the ABG II.* This recall came just years after the FDA approved the Rejuvenate device in June 2008 device and the ABG II device in November 2009. On its website, Stryker explained that the recall was issued “due to the potential for fretting and corrosion at the modular neck joint.” Both of these products were designed using the metal-on-metal method, which the FDA has expressed concerns about. Specifically, the FDA has stated concerns about the potential for corrosion and the release of metal ions from these devices.**
According to the FDA, metal-on-metal hip replacements like Stryker’s Rejuvenate Modular or ABG II may cause side effects like swelling, pain, infection, osteolysis, device loosening, fracture, or dislocation. Like any joint implant, the components of a metal-on-metal slide against each other thus increasing the risk of metal particles created when the components slide against each other.** In addressing this issue the FDA states that “Different people will react to these metal particles in different ways. At this time, it is not possible to predict who will experience a reaction, what type of reaction they might have, when the reaction will occur, or how severe the reaction will be. ”***
The Stryker infographic provides a list of possible side effects as well as providing information about FDA warnings and alerts to Stryker. Visit the Stryker webpage and view the infographic at dmlaw.com
If you or a loved one has experienced pain, fracture, dislocation, or device failure from a Stryker hip replacement, you may want to speak with a personal injury lawyer regarding a potential claim. d’Oliveira & Associates, P.C, is working with some of the leading Stryker lawyers in the country who are handling these cases.
Please contact the law offices of d’Oliveira & Associates, P.C. at 1-800-992-6878 or dmlaw.com for a free legal consultation.